Rega Tumbas Perusahaan: Greenwich LifeSciences Inc (GLSI)

The current market value of Greenwich LifeSciences (GLSI) shown on this chart is 259.88. Business protection is ensured by strict patents and the high cost of final GP2 vaccine tests, which blocks new entrants. Demand for the therapy is independent of economic or seasonal factors, demonstrating resilience to crises. The current development vector is focused on completing trials for a drug to combat relapses.

Nilai Perusahaan: Greenwich LifeSciences Inc. (GLSI) kanggo 23.11.2025 - 29.10.2026

Greenwich LifeSciences (GLSI) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:

Bagan rega Greenwich LifeSciences Inc.|GLSI - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Greenwich LifeSciences|GLSI - Nilai Perusahaan

- data ekuitas miturut neraca:

Aset Bersih saben Saham Greenwich LifeSciences|GLSI - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku greenwichlifesciences.com|GLSI - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Rasio Kabeh Utang marang Dana Pribadi Greenwich LifeSciences|GLSI - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal greenwichlifesciences.com|GLSI - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Greenwich LifeSciences|GLSI - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Greenwich LifeSciences

Ringkesan analitik perusahaan:GLSI (Greenwich LifeSciences Inc.)

Produk merek Greenwich LifeSciences, Inc

The success of Phase III trials for a breast cancer vaccine requires colossal capital in the absence of current sales for Greenwich LifeSciences (GLSI). An analysis of the adjusted enterprise value allows for an assessment of the asset's real price by summing the market capitalization with debt and subtracting liquid assets, which reveals the actual cost of ownership and the company's financial stability during a period of high operating expenses.

Pesaing Greenwich LifeSciences (GLSI)